Fermenta Biotech reappoints two executive directors for three-year terms

Fermenta Biotech Limited confirmed the re-appointment of Anupama Datla Desai and Satish Varma as executive directors for a three-year term, effective from September 27, 2025, to September 26, 2028. This decision follows approval from members at their meeting on August 12, 2025.

Desai brings nearly two decades of industry experience, specializing in quality control, safety policy implementation, and spearheading new technology platforms and business development. Varma boasts over three decades of operational, management, and legal expertise, having played a crucial role in strategic events such as the Solvay demerger in 2000 and the Crocin brand sale in 1996. He has led the growth of the company's vitamin D3 business since 1998.

Desai is related to other directors: she is the daughter of Rajeshwari Datla, a non-executive director, and the sister of Krishna Datla, the executive-vice chairman. No relationships between directors were disclosed for Varma.